CLINICAL_TRIALS
trial_result
· 2022-07-29
Clinical Trial Update: Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne [Phase 4]
Summary
Phase 4 trial comparing Differin Gel over 12 weeks and Tazorac Cream over 12 weeks, with a 6-week Differin-to-Tazorac switch, in acne vulgaris.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED